Baodong Ling
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 5%
- Vibrio bacteria research studies
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 17
-
- Bacterial biofilms and quorum sensing 9
- Metabolism, Diabetes, and Cancer 3
- Co-authors
- Lin Li (1 shared paper)Xian-Zhi Li (1 shared paper)Fei Lin (12 shared papers)Xu Jia (4 shared papers)Yao‐Wen Chang (4 shared papers)Brigitte Berger‐Bächi (1 shared paper)Ying Xu (2 shared papers)Min Shen (3 shared papers)
- Journals
- Scientific Reports (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)BMC Infectious Diseases (2 papers)Frontiers in Pharmacology (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Baodong Ling
27 papers receiving 422 citations
Peers
Comparison fields: 5 of 70
- Molecular Medicine 286
- Endocrinology 132
- Applied Microbiology and Biotechnology 27
- Pollution 101
- Microbiology 29
Countries citing papers authored by Baodong Ling
This map shows the geographic impact of Baodong Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baodong Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baodong Ling more than expected).
Fields of papers citing papers by Baodong Ling
This network shows the impact of papers produced by Baodong Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baodong Ling. The network helps show where Baodong Ling may publish in the future.
Co-authors
The 25 scholars most cited alongside Baodong Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 104 | |
| 2 | 2015 | 58 | |
| 3 | 2017 | 43 | |
| 4 | 2023 | 35 | |
| 5 | 1998 | 28 | |
| 6 | 2020 | 19 | |
| 7 | 2021 | 17 | |
| 8 | 2016 | 15 | |
| 9 | 2014 | 15 | |
| 10 | 2023 | 14 | |
| 11 | Molecular characterization of extended-spectrum beta-lactamases produced by clinical isolates of Enterobacter cloacae from a Teaching Hospital in China. | 2008 | 10 |
| 12 | 2021 | 9 | |
| 13 | 2006 | 9 | |
| 14 | 2008 | 8 | |
| 15 | 2015 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2022 | 7 | |
| 18 | Characterization of CTX-M-22 and TEM-141 Encoded by a single plasmid from a clinical isolate of Enterobacter cloacae in China. | 2007 | 6 |
| 19 | 2023 | 5 | |
| 20 | 2007 | 5 |
About Baodong Ling
Baodong Ling is a scholar working on Molecular Medicine, Molecular Biology, Endocrinology, Pharmacology and Epidemiology, having authored 28 papers that have together received 436 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (17 papers), Bacterial biofilms and quorum sensing (9 papers), Vibrio bacteria research studies (5 papers), Metabolism, Diabetes, and Cancer (3 papers), Pharmaceutical and Antibiotic Environmental Impacts (3 papers), Diabetes Treatment and Management (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers) and Enterobacteriaceae and Cronobacter Research (2 papers). The work is most often cited by research in Molecular Medicine (286 citations), Endocrinology (132 citations), Applied Microbiology and Biotechnology (27 citations), Pollution (101 citations) and Microbiology (29 citations). Baodong Ling has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Lin Li, Xian-Zhi Li, Fei Lin, Xu Jia, Yao‐Wen Chang, Brigitte Berger‐Bächi, Ying Xu, Min Shen, Qin Peng and Bin Yu. Their work appears in journals such as Scientific Reports, Antimicrobial Agents and Chemotherapy, BMC Infectious Diseases, Frontiers in Pharmacology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.